COVID-19: Vaccines and Therapeutics
The AHA released Kids, COVID-19 and Vaccines, a video to encourage vaccination among the newly eligible children aged 5-11.
The Centers for Medicare & Medicaid Services issued an interim final rule requiring COVID-19 vaccinations for workers in most health care settings, including hospitals and health systems, that participate in the Medicare and Medicaid programs.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11.
Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky, M.D., last night accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of 5 and 11. The…
In a study of over 89,000 adults hospitalized with COVID-19 symptoms, prior vaccination with two doses of the Pfizer or Moderna vaccine was 77% effective in preventing COVID-19 in immunocompromised patients compared with 90% effective in immunocompetent patients, the Centers for Disease Control and…
The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11.
Moderna announced an updated timeline for its COVID-19 vaccine for children. According to Moderna, the Food and Drug Administration last week notified the drug maker that it may not complete its assessment of the company’s EUA request for children age 12 to 17 before January 2022.
The recent expansion of COVID-19 booster shots for certain adult Americans means that millions more people are now eligible to seek extra protection against the deadly virus.
The Food and Drug Administration authorized Pfizer’s COVID-19 vaccine for pediatric use, moving the issue of administration to the Centers for Disease Control and Prevention for consideration.
The American Medical Association published a Current Procedural Terminology code for providers administering a booster dose of the Johnson & Johnson COVID-19 vaccine.